141 related articles for article (PubMed ID: 37733085)
1. Silencing POLE2 promotes apoptosis and inhibits proliferation of oral squamous cell carcinomas by inhibiting PI3K/AKT signaling pathway.
Ge S; Wang K; Meng Y; He Z; Yang X; Shang W; Wang L
Med Oncol; 2023 Sep; 40(10):304. PubMed ID: 37733085
[TBL] [Abstract][Full Text] [Related]
2. POLE2 Regulates Apoptosis of Oral Squamous Cell Carcinoma Cells through the PI3K/AKT Signaling Pathway.
Sun MY; Wang L; Shen ZY
Curr Med Sci; 2023 Dec; 43(6):1162-1172. PubMed ID: 38079056
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-134 inhibits tumor stem cell migration and invasion in oral squamous cell carcinomas via downregulation of PI3K-Akt signaling pathway by inhibiting LAMC2 expression.
Zhou YM; Yao YL; Liu W; Shen XM; Shi LJ; Wu L
Cancer Biomark; 2020; 29(1):51-67. PubMed ID: 32568182
[TBL] [Abstract][Full Text] [Related]
4. PSMC2 knockdown inhibits the progression of oral squamous cell carcinoma by promoting apoptosis via PI3K/Akt pathway.
Wang Z; Xiong H; Zuo Y; Hu S; Zhu C; Min A
Cell Cycle; 2022 Mar; 21(5):477-488. PubMed ID: 34979867
[TBL] [Abstract][Full Text] [Related]
5. Overproduced CPSF4 Promotes Cell Proliferation and Invasion via PI3K-AKT Signaling Pathway in Oral Squamous Cell Carcinoma.
Zhang M; Lin H; Ge X; Xu Y
J Oral Maxillofac Surg; 2021 May; 79(5):1177.e1-1177.e14. PubMed ID: 33535057
[TBL] [Abstract][Full Text] [Related]
6.
Tang KL; Tang HY; Du Y; Tian T; Xiong SJ
Biosci Rep; 2019 Jul; 39(7):. PubMed ID: 31213575
[No Abstract] [Full Text] [Related]
7. POLE2 knockdown reduce tumorigenesis in esophageal squamous cells.
Zhu Y; Chen G; Song Y; Chen Z; Chen X
Cancer Cell Int; 2020; 20():388. PubMed ID: 32831648
[TBL] [Abstract][Full Text] [Related]
8. As a Novel Tumor Suppressor, LHPP Promotes Apoptosis by Inhibiting the PI3K/AKT Signaling Pathway in Oral Squamous Cell Carcinoma.
Liu S; Gao W; Lu Y; Zhou Q; Su R; Hasegawa T; Du J; Li M
Int J Biol Sci; 2022; 18(2):491-506. PubMed ID: 35002505
[TBL] [Abstract][Full Text] [Related]
9. miR-186-5p inhibits the progression of oral squamous cell carcinoma by targeting ITGA6 to impair the activity of the PI3K/AKT pathway.
Chen M; Zhang J
J Oral Pathol Med; 2022 Apr; 51(4):322-331. PubMed ID: 35201653
[TBL] [Abstract][Full Text] [Related]
10. Circ_0058063 Contributed to Oral Squamous Cell Carcinoma Development by Sponging miR-145 and Regulating PI3K/AKT Pathway.
Zhou J; Jin S
Mol Biotechnol; 2023 Dec; 65(12):2049-2060. PubMed ID: 36928742
[TBL] [Abstract][Full Text] [Related]
11. FERMT1 knockdown inhibits oral squamous cell carcinoma cell epithelial-mesenchymal transition by inactivating the PI3K/AKT signaling pathway.
Wang X; Chen Q
BMC Oral Health; 2021 Nov; 21(1):598. PubMed ID: 34814915
[TBL] [Abstract][Full Text] [Related]
12. Abnormal downregulation of 10-formyltetrahydrofolate dehydrogenase promotes the progression of oral squamous cell carcinoma by activating PI3K/Akt/Rb pathway.
Qu Y; He Y; Ruan H; Qin L; Han Z
Cancer Med; 2023 Mar; 12(5):5781-5797. PubMed ID: 36336972
[TBL] [Abstract][Full Text] [Related]
13. LINC00961 suppresses cell proliferation and induces cell apoptosis in oral squamous cell carcinoma.
Pan LN; Sun YR
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3358-3365. PubMed ID: 31081090
[TBL] [Abstract][Full Text] [Related]
14. The circEPSTI1/mir-942-5p/LTBP2 axis regulates the progression of OSCC in the background of OSF via EMT and the PI3K/Akt/mTOR pathway.
Wang J; Jiang C; Li N; Wang F; Xu Y; Shen Z; Yang L; Li Z; He C
Cell Death Dis; 2020 Aug; 11(8):682. PubMed ID: 32826876
[TBL] [Abstract][Full Text] [Related]
15. Spindle and kinetochore-associated complex 3 promotes cell growth via the PI3K/AKT/GSK3β and PI3K/AKT/FOXO1 pathways and is a potential prognostic biomarker for oral squamous cell carcinoma.
Xu H; Chen G; Niu Q; Song K; Feng Z; Han Z
Oral Surg Oral Med Oral Pathol Oral Radiol; 2022 Nov; 134(5):599-614. PubMed ID: 36123287
[TBL] [Abstract][Full Text] [Related]
16. Increased expression of lncRNA FTH1P3 promotes oral squamous cell carcinoma cells migration and invasion by enhancing PI3K/Akt/GSK3b/ Wnt/β-catenin signaling.
Liu M; Gao X; Liu CL
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8306-8314. PubMed ID: 30556871
[TBL] [Abstract][Full Text] [Related]
17. The role of p21-activated kinase 4 in the progression of oral squamous cell carcinoma by targeting PI3K-AKT signaling pathway.
Zhang L; Lin S; Zhang Z; Yan C; Liu F
Clin Transl Oncol; 2023 Mar; 25(3):739-747. PubMed ID: 36593383
[TBL] [Abstract][Full Text] [Related]
18. Downregulation of PER2 Promotes Tumor Progression by Enhancing Glycolysis via the Phosphatidylinositol 3-Kinase/Protein Kinase B Pathway in Oral Squamous Cell Carcinoma.
Long W; Gong X; Yang Y; Yang K
J Oral Maxillofac Surg; 2020 Oct; 78(10):1780.e1-1780.e14. PubMed ID: 32615095
[TBL] [Abstract][Full Text] [Related]
19. Propionate-producing Veillonella parvula regulates the malignant properties of tumor cells of OSCC.
Chang X; Chen Y; Cui D; Wang Y; Zhou Y; Zhang X; Tang G
Med Oncol; 2023 Feb; 40(3):98. PubMed ID: 36808012
[TBL] [Abstract][Full Text] [Related]
20. Carboxylesterase 2 induces mitochondrial dysfunction via disrupting lipid homeostasis in oral squamous cell carcinoma.
Chen X; Liu Q; Chen Y; Wang L; Yang R; Zhang W; Pan X; Zhang S; Chen C; Wu T; Xia J; Cheng B; Chen X; Ren X
Mol Metab; 2022 Nov; 65():101600. PubMed ID: 36113774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]